Document is current

Article History

Received: 31 January 2026

Revised: 7 July 2026

Accepted: 17 July 2026

First Online: 25 July 2026

Ethics

Competing interests: JM is co-inventor of dynamic BH3 profiling (developed by the Letai laboratory and patented by Dana-Faber Cancer Institute) and has received royalties, is a paid consultant for PEP-THERAPY, was a paid consultant for Oncoheroes Biosciences and Vivid Biosciences, and is an unpaid board member of the Society for Functional Precision Medicine.

Declaration of generative AI and AI-assisted technologies in the writing process: During the preparation of this work, the authors used Gemini to improve the readability and language of the manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.